SCHEMBL6004328

SCHEMBL6004328

CCCCCCCCCC1=C2C=CC(=N2)C(I)=C2C=CC(=N2)C(I)=C2C=CC(=N2)C(I)=C2C=CC1=N2.[Zn]

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 9/20 0.33
▸ MPEG1 Q2M385 7/20 0.33
▸ XIAP P98170 2/20 0.33
▸ GPR84 Q9NQS5 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ PTGES O14684 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KAT2B Q92831 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL434101 0.88 KCNH2 (0.38) ALOX5MPEG1XIAPGPR84MAPT
SCHEMBL1194296 0.87 KCNH2 (0.35) ALOX5MPEG1XIAPGPR84MAPT
SCHEMBL17419219 0.79 KCNH2 (0.33) ALOX5MPEG1XIAPGPR84MAPT
SCHEMBL6003914 0.72 ALOX5 (0.31) ALOX5MPEG1XIAPGPR84MAPT
SCHEMBL5011897 0.71 KCNH2 (0.36) GPR84KCNH2
SCHEMBL17681578 0.70 CASP3 (0.42) MAPTPTGESALDH1A1HPGD
SCHEMBL1772836 0.70 ALOX5 (0.30) ALOX5MPEG1XIAPGPR84MAPT
SCHEMBL2337738 0.68 GCGR (0.40) ALOX5MAPTKDM4EMEN1ALDH1A1
SCHEMBL2313952 0.68 GCGR (0.40) ALOX5MAPTKDM4EMEN1ALDH1A1
SCHEMBL5602439 0.55 THRB (0.40) ALOX5MPEG1XIAPGPR84MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060293249-A1 Porphyrin derivatives PHOTOBIOTICS LIMITED 2006-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293249-A1 Porphyrin derivatives SLC2A3, SLC2A2, SCO2 ALOX5 2592/4885MPEG1 2096/4885XIAP 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback